Article Text

Download PDFPDF

Understanding bone fragility: theoretical explanation to non-physician health professionals
Free
  1. Toshihiro Sugiyama
  1. Department of Orthopaedic Surgery, Saitama Medical University, Saitama 350-0495, Japan
  1. Correspondence to Dr Toshihiro Sugiyama, Department of Orthopaedic Surgery, Saitama Medical University, Saitama 350-0495, Japan; tsugiym{at}saitama-med.ac.jp

Statistics from Altmetric.com

The European League Against Rheumatism recently established timely and highly important recommendation for non-physician health professionals regarding the prevention and management of bone fractures among older adults.1 To support the health professionals’ understanding of skeletal fragility, I would like to provide a theoretical explanation.2 3

First, non-physician health professionals are expected to play a role in the improvement of patient adherence to pharmacotherapy for osteoporosis.1 Here, it should be paid attention that the effects of osteoporosis drugs except bisphosphonates with mineral binding capacity are lost rapidly after discontinuation,4 which can be reasonably explained by functional adaptation of bone to mechanical loading during physical activity.3 Second, the homeostatic system in the skeleton2 can also explain why the small and transient effect of calcium supplementation on areal bone mineral density, measured by dual-energy X-ray absorptiometry, is lost after discontinuation.5 Finally, although vigorous-intensity exercise would improve bone fragility,6 the effect can be similarly lost after discontinuation, resulting from the skeletal adaptation to mechanical environment.7 Long-term continuation of exercise should be therefore given priority over the intensity; for example, rapid bone loss following stroke8 indicates the significance of even light-intensity physical activity.

Ethics statements

Patient consent for publication

References

Footnotes

  • Contributors TS is the sole author.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Linked Articles